1 January 2014 in BioMed Research International
Telomeres protect and cap linear chromosome ends, yet these genomic buffers erode over an organism’s lifespan. Short telomeres have been associated with many age-related conditions in humans, and genetic mutations resulting in short telomeres in humans manifest as syndromes of precocious aging. In women, telomere length limits a fertilized egg’s capacity to develop into a healthy embryo. Thus, telomere length must be reset with each subsequent generation. Although telomerase is purportedly responsible for restoring telomere DNA, recent studies have elucidated the role of alternative telomeres lengthening mechanisms in the reprogramming of early embryos and stem cells, which we review here.
30 December 2014 in Reproductive Sciences
1 April 2009 in The FASEB Journal
The mechanisms underlying neuron loss in central nervous system disorders are incompletely understood. We have previously identified dysregulation in several pathways important to neuronal health. In this study, we focus on identifying regulatory factors that could be used to protect and preserve neuronal function following traumatic brain injury (TBI). Elucidation of factors involved in neuronal death will provide targets to achieve therapeutic benefits during a narrow window of opportunity after TBI. Using an in vitro cell injury model, we identified several transcription factors that are upregulated that can result in a proapoptotic gene expression profile, including E26 avian leukemia oncogene 1 (ETS1), interferon regulatory factors (IRF3 and 6), MAD homolog 3 (Smad3), and Wilms tumor homolog (WT1). The expression levels of these factors were elevated about 1.7 fold and 3.5 fold in the case of ETS1. Our data indicate that inflammatory responsive transcription factors, implicated in apoptosis in other tissues, are also important in cell loss in the brain. The identification of these and other factors that regulate neuronal survival following TBI may represent an attractive target for pharmacological intervention. This study was supported by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs, the Bay Pines Foundation, and the Alzheimer's Association.